Author & Editor: Adam Tomlinson
Clinically Reviewed by: Charee Marquez, LMFT
Clinical Contributor: Karynne Witkin, M.A. I/O Psychology
Understanding Microdosing Mushrooms
Microdosing psilocybin-containing mushrooms involves taking very small amounts of psychedelic compounds and has gained attention for potential mental health benefits. Interest has grown around its possible impact on depression, anxiety disorders, and other mental disorders, alongside a growing body of anecdotal reports, survey data, and observational studies. However, while anecdotal reports and surveys suggest positive effects, the scientific community remains cautious. Current research emphasizes the need to distinguish true therapeutic effects from the placebo effect and to better understand why people microdose, including for mood support or self-improvement, as well as potential risks such as anxiety or physical discomfort. More controlled studies are needed to evaluate long-term outcomes and overall safety.
What Is Psilocybin Microdosing Mushrooms?
Psilocybin microdosing refers to consuming a very low dose—approximately 5–10% of a typical recreational dose—of psychedelic substances such as psilocybin mushrooms or LSD. This is considered a subperceptual dose, meaning it is much lower than what would cause hallucinations or noticeable perceptual changes. At these low doses, individuals do not experience hallucinations or intense perceptual changes.
A typical microdose of psilocybin mushrooms is widely accepted to be in the range of 0.1 to 0.3 grams of dried mushrooms.
Instead, proponents report subtle effects such as improved mood, focus, emotional balance, creativity, and the ability to boost mood. While many describe these benefits as meaningful, scientific evidence remains limited, and most studies have not found a significant effect, so ongoing research is needed to clarify effectiveness, dosing consistency, and potential risks. While there are widely accepted protocols for microdosing, individual responses may vary.
What Are Psilocybin Mushrooms?
Psilocybin mushrooms—commonly known as “shrooms” or “magic mushrooms”—are a type of psychedelic mushrooms and are fungi containing the psychoactive compounds psilocybin and psilocin. Dried psilocybe cubensis mushrooms are commonly used in microdosing due to their psilocybin content. When ingested, psilocybin converts into psilocin, which interacts with serotonin receptors in the brain and alters perception, mood, and thought patterns. Historically used in spiritual and ceremonial contexts, these psychedelic drugs became widely known in Western culture during the 20th century. While some individuals use psilocybin for exploration, creativity, or self-reflection, risks include anxiety, paranoia, and psychological distress, particularly for those with underlying mental health conditions.
Types of Microdosing
Microdosing can involve a variety of substances, each with its own unique effects and potential benefits. Here are some of the most common types of microdosing:
Psilocybin Mushrooms (Shrooms): One of the most popular substances for microdosing, psilocybin mushrooms contain the psychoactive compound psilocybin, which is converted into psilocin in the body. Microdosing psilocybin is often reported to enhance mood, creativity, and cognitive function without inducing intense hallucinations or a full-blown psychedelic experience. Studies have shown that microdosing psilocybin can improve performance on various cognitive tasks, highlighting its potential to enhance cognitive function.
LSD (Lysergic Acid Diethylamide): Another widely used substance for microdosing, LSD is a powerful synthetic hallucinogen. When taken in microdoses, users often report improved focus, heightened creativity, and increased emotional resilience. Like psilocybin, the effects are subtle and usually do not include the dramatic visual or perceptual changes seen with higher doses.
MDMA (3,4-Methylenedioxymethamphetamine): Although less common, some individuals microdose MDMA, the active ingredient in ecstasy. Microdoses of MDMA are believed to enhance mood, empathy, and social connection, though the practice is controversial due to the potential neurotoxic effects of MDMA.
Ayahuasca: This traditional South American brew, which contains the psychoactive compound DMT (Dimethyltryptamine), is sometimes used in microdoses to promote emotional healing and spiritual growth. The effects are typically more subtle than those of a full ayahuasca ceremony but can still foster deep introspection and emotional release.
Ibogaine: Derived from the iboga plant, ibogaine is often used in microdoses for its potential to treat addiction and mental health issues. It is known for its powerful psychoactive effects in larger doses, but in microdoses, it is believed to help users break negative patterns of behavior and thought.
Cannabis (THC or CBD): Some individuals microdose cannabis, particularly THC or CBD, to manage anxiety, pain, or depression. Microdosing THC can provide mild euphoria and relaxation, while CBD is often used for its calming and anti-inflammatory properties without the psychoactive effects.
Nootropics: While not traditionally psychedelic, nootropics are often used in microdoses to enhance cognitive function, memory, and focus. Examples include substances like microdosed caffeine, racetams, or other cognitive enhancers.
Each type of microdosing offers different potential benefits and risks, and individuals may choose a substance based on their specific goals, such as improving mental clarity, emotional balance, or creativity. However, the effects of microdosing can vary widely, and more research is needed to fully understand the long-term implications and effectiveness of this practice.
How Much is a Microdose?
A microdose of psilocybin mushrooms typically ranges between 0.1 to 0.3 grams of dried mushrooms. This amount is generally around 5-10% of a standard recreational dose, which usually falls between 1 to 3.5 grams. The goal of microdosing is to consume a dose that is sub-perceptual, meaning it does not cause significant alterations in consciousness, such as hallucinations or a strong psychedelic experience. Instead, users often report subtle effects, such as enhanced mood, increased focus, and greater creativity. However, the exact amount can vary depending on the individual’s body weight, tolerance, and sensitivity to psilocybin. It’s important to start with a lower dose and adjust gradually to find the optimal amount that provides the desired benefits without overwhelming effects.
Microdosing magic mushrooms involves small, sub-perceptual psychedelic use for potential cognitive and emotional benefits.
How Long Does Microdosing Last?
The effects of microdosing typically last between 4 to 6 hours, depending on the substance used (such as psilocybin or LSD), individual body chemistry, and dosage. Understanding proper dosing practices is essential, as following established protocols for microdose quantities and schedules can influence both mental health outcomes and safety. Unlike full doses, microdoses are sub-perceptual, meaning they don’t produce intense hallucinations but may subtly enhance mood, focus, and creativity. Some individuals report residual benefits lasting into the next day, although microdosing schedules often include rest days to prevent tolerance buildup. For first-time microdosers, it is commonly recommended to try microdosing on a day without responsibilities or commitments to ensure safety and proper adjustment.
Positive Effects of Microdosing Mushrooms
Microdosing psilocybin mushrooms is reported to offer several potential benefits, though scientific research is still emerging. Surveys such as the Global Drug Survey suggest many individuals report improvements in mood, creativity, and overall well-being. Commonly reported effects include:
Enhanced Mood:
Many people report improved mood and reduced stress, anxiety, or depressive symptoms. Some of these benefits may be influenced by expectancy or placebo effects.Increased Creativity:
Microdosing is often linked to enhanced creative thinking, problem-solving, and flexibility in perspective, which some find helpful in artistic or professional settings.Improved Focus and Productivity:
Some individuals report better concentration, task engagement, and productivity, particularly in cognitively demanding environments.Greater Emotional Resilience:
Users may feel better equipped to manage stress and emotional challenges, supporting a more balanced emotional state.Reduced Symptoms of Depression and Anxiety:
Early research and anecdotal reports suggest potential relief of depression and anxiety symptoms, though findings remain preliminary and require further clinical validation.Enhanced Mindfulness and Presence:
Many report greater awareness and presence in daily life, contributing to improved appreciation of everyday experiences.Improved Social Interaction:
Some individuals experience increased empathy, openness, and ease in social settings.Potential Cognitive Enhancement:
Limited evidence suggests possible benefits to learning, memory, or cognitive flexibility, though these effects are not yet well established.Spiritual Growth and Self-Reflection:
Some users describe increased self-reflection or a sense of personal insight and meaning.
While these reported effects are promising, outcomes vary widely, and long-term safety is not fully understood. Anyone considering microdosing should approach it cautiously and consult a healthcare professional, especially if they have existing mental health conditions.
Is Microdosing Mushrooms Safe?
Microdosing psilocybin mushrooms can be relatively safe for some individuals, but it carries risks due to limited research on long-term effects. Potential short-term risks include anxiety, paranoia, and altered perception, while long-term risks are not well understood. It’s also illegal in many places, adding legal risks. People with underlying mental health conditions should be particularly cautious. Consulting a healthcare professional before microdosing is advised.
Psychedelic drugs, like psilocybin-containing mushrooms, show promise for mental illness such as post-traumatic stress disorder and treatment-resistant depression, with research suggesting benefits for major depressive disorder being generally consistent.
Physical health benefits of what is microdosing lack a clearly recognized definition, relying on anecdotal evidence rather than a significant benefit proven by research.
How Does Microdosing Mushrooms Work in the Brain and Body for Mental Health Conditions?
Microdosing psilocybin mushrooms involves taking small, sub-perceptual doses of psilocybin, which is converted into psilocin in the body. Psilocin primarily binds to serotonin receptors in the brain, especially the 5-HT2A receptor, influencing mood, perception, and cognition. This interaction can promote neuroplasticity, enhancing brain connectivity and cognitive flexibility, which may lead to improved mood, creativity, and emotional resilience. Psychoactive substances may influence anxiety, depression, concentration, and chronic pain in people with various mental health conditions when used under a medical professional’s guidance.
Microdosing also subtly modulates the Default Mode Network (DMN), reducing self-focused thinking and promoting a more open mindset. The effects are typically mild, without the intense psychoactive experiences of larger doses, allowing users to experience benefits such as enhanced focus and mood without significant alterations in consciousness. While promising, more research is needed to fully understand the long-term effects and safety of microdosing.
Side Effects and Risks of Microdosing Mushrooms
Short-Term Side Effects and Risks:
Anxiety and Paranoia: Even at low doses, some individuals may experience heightened anxiety or paranoia.
Physical Discomfort: Nausea, dizziness, and mild gastrointestinal discomfort are possible.
Cognitive Impairment: While rare, some users may find it harder to focus or think clearly, especially if the dose is slightly too high. Psychedelic drugs at an active dose compared using the PSS Perceived Stress Scale and the Negative Affect Scale, show effects on divergent and convergent thinking.
Altered Perception: Subtle changes in perception or sensory sensitivity can occur, which might be unsettling for some users.
Long-Term Side Effects and Risks:
Tolerance Development: Regular microdosing can lead to tolerance, requiring higher doses over time to achieve the same effects.
Mental Health Risks: For individuals with underlying mental illness, even microdosing can trigger or worsen symptoms like anxiety or mania.
Legal Risks: Psilocybin remains illegal in many places, so possession or use can result in legal consequences.
Unknown Long-Term Effects: The long-term safety of microdosing is not well studied, and potential risks over extended periods remain unclear.
While many users report positive experiences, it’s important to approach microdosing with caution, especially if you have pre-existing health conditions or are unsure of the legal status in your area.
Legal Status of Microdosing Mushrooms
The legal status of microdosing psilocybin mushrooms varies significantly around the world. In the United States, psilocybin is classified as a Schedule I controlled substance, making it illegal under federal law, though some states and cities, like Oregon and Denver, have decriminalized or legalized its use under specific conditions. In Canada, psilocybin is generally illegal, but exemptions are granted for certain therapeutic uses. In Europe, the Netherlands permits the sale of “magic truffles,” while other countries like Portugal have decriminalized possession of all drugs, including psilocybin. However, in most regions worldwide, psilocybin remains illegal, with harsh penalties for possession and use. As interest in microdosing grows, so does advocacy for its legalization, particularly for medical and therapeutic applications, but the legal landscape remains complex and varies by location.
The Federal Controlled Substances Act, enforced by the Drug Enforcement Agency, regulates LSD and other psychedelic substances.
Can You Overdose on Mushrooms?
It is technically possible to overdose on psilocybin mushrooms, but a fatal overdose is extremely rare. Psilocybin mushrooms have a very low toxicity level, meaning that the physical risk of overdose is minimal compared to many other substances. A microdose is much smaller than a regular dose, which is the standard amount used for full psychedelic effects. Taking a regular dose can lead to an intense and overwhelming psychedelic experience, often referred to as a “bad trip.” This can cause severe anxiety, paranoia, hallucinations, and disorientation, which can be distressing and potentially dangerous, especially if the person is in an unsafe environment or has underlying mental health issues.
How Does Microdosing Mushrooms Interact with Other Substances?
Microdosing psilocybin mushrooms can interact with other substances in various ways:
Antidepressants: May diminish the effects of psilocybin or increase the risk of serotonin syndrome.
Alcohol: Can amplify impairment and emotional volatility, reducing the cognitive benefits of microdosing.
Cannabis: May enhance psychedelic effects but could also increase anxiety or paranoia.
Caffeine: Might boost focus and energy but can also heighten anxiety in some individuals.
Benzodiazepines: Can reduce the effects of psilocybin and are sometimes used to manage anxiety during a trip.
Stimulants: May lead to overstimulation and increased anxiety, although they could enhance focus.
Opioids: Interactions are unclear but may dull effects or cause unpredictable emotional responses.
Combining substances should be approached cautiously due to potential risks and unpredictable effects.
Microdosing Mushrooms and Pregnancy
Microdosing psilocybin mushrooms during pregnancy is not recommended due to the lack of research on its safety and potential effects on fetal development. Psilocybin can cross the placenta, potentially affecting the developing baby. Additionally, the psychological effects, even at microdoses, could contribute to stress or anxiety, which might impact both the mother and the fetus. Given the unknown risks and the importance of ensuring a safe and healthy pregnancy, it is best to avoid microdosing or any psychedelic substances during this time. Always consult with a healthcare provider before taking any substances while pregnant.
Signs of Mushroom Addiction
Here are some potential signs of mushroom addiction:
Cravings for Psilocybin: A strong, persistent desire to use mushrooms despite not intending to or needing to.
Increased Tolerance: Needing to take larger doses over time to achieve the same effects.
Using More Frequently: Increasing the frequency of use, even when not microdosing, to maintain the effects.
Neglecting Responsibilities: Ignoring or neglecting personal, professional, or social responsibilities due to mushroom use.
Continued Use Despite Negative Consequences: Persisting in using mushrooms even after experiencing adverse effects, such as anxiety, paranoia, or relationship problems.
Failed Attempts to Cut Down or Quit: Repeated unsuccessful efforts to reduce or stop using mushrooms.
Preoccupation with Use: Spending a significant amount of time thinking about, obtaining, or using mushrooms.
Social Withdrawal: Avoiding social situations or activities that do not involve mushroom use.
Using in Dangerous Situations: Consuming mushrooms in risky situations, such as while driving or in unsafe environments.
Physical or Psychological Dependence: Experiencing withdrawal symptoms or distress when not using mushrooms, though physical dependence on psilocybin is less common than psychological dependence.
Treatment Options for Mushroom Addiction
Treatment options for mushroom addiction include:
Behavioral Therapy: Cognitive-behavioral therapy (CBT) helps individuals identify and change harmful thought patterns and behaviors related to substance use.
Counseling: Individual or group counseling provides support, coping strategies, and accountability.
Support Groups: Joining groups like Narcotics Anonymous (NA) offers peer support and shared experiences in recovery.
Detoxification: Medical supervision during withdrawal to manage symptoms and ensure safety.
Inpatient or Outpatient Rehab: Structured programs offering comprehensive treatment, including therapy, counseling, and support services.
Medication Management: While no specific medications are approved for psilocybin addiction, medications may be used to treat co-occurring mental health issues.
Seeking professional help is crucial for effective recovery and long-term success.
Does Insurance Cover Treatment?
Yes, many insurance plans do cover treatment for substance use disorders, including addiction to psilocybin mushrooms. Coverage can include various services such as therapy, counseling, inpatient or outpatient rehab, and medication management. The extent of coverage depends on the specific insurance policy and provider, so it’s important to review your plan details or contact your insurance company to understand what is covered. Additionally, some states require insurance plans to cover addiction treatment as part of mental health services.
Conclusion and Future Research
As the practice of microdosing psychedelic drugs continues to rise, it is crucial to approach the perceived outcomes with a critical eye. While preclinical evidence and early studies suggest potential therapeutic value, particularly in improving mental health and decreasing depressive symptoms, the need for further research is undeniable. Future studies must include rigorous control groups and data analysis to better understand the significant differences in the relationship between microdosing with psychedelics and mental health concerns. Until more systematic reviews and clinical trials are conducted, including studies that explore the effects on psychiatric comorbidities like bipolar disorder, the conclusions drawn from current research should be viewed cautiously. As we look toward future research, the focus must remain on ensuring that any health-related motivations for exploring psychedelic microdosing are grounded in scientific evidence and a clear understanding of both the positive and potential negative effects.
Seeking Treatment? We Can Help!
At California Prime Recovery, as an in-network provider we work with most insurance plans, such as:
And More
If you or a loved one are struggling with mental health challenges or substance abuse, reach out to California Prime Recovery today. Our team of compassionate professionals is here to support your journey towards lasting well-being. Give us a call at 866-208-2390.
Also, check out our blogs posted weekly on Medium.
FAQs
What is microdosing?
Microdosing involves taking very small, sub-perceptual doses of psilocybin mushrooms to enhance mood, creativity, and cognitive function without experiencing intense psychedelic effects.
Is microdosing mushrooms legal?
The legality varies by location. Psilocybin is illegal in many countries, but some places have decriminalized or allowed it for therapeutic use.
What are the benefits of microdosing?
Reported benefits include improved mood, increased creativity, enhanced focus, and emotional resilience, though scientific evidence is still limited.
What are the risks of microdosing?
Risks include anxiety, paranoia, potential legal issues, and unknown long-term effects. It’s especially risky for individuals with mental health conditions.
Can microdosing psychedelics help with alcohol use disorder?
Emerging research suggests that microdosing psychedelics may offer potential benefits for individuals with alcohol use disorder, but more clinical studies are needed to confirm its safety and effectiveness.
Can magic mushrooms play a role in treating mental illness?
Emerging studies suggest psilocybin, found in magic mushrooms, may help treat certain mental health disorders when used in controlled clinical settings.
How often should you microdose?
Common schedules include taking a microdose every three days or following the “Fadiman” protocol of one day on, two days off, but this varies based on individual preferences and goals.